Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adamis Pharmaceuticl (NQ: ADMP )

2.160 -0.040 (-1.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Adamis Pharmaceuticl

< Previous 1 2 3 4 5 Next >
ADMP Stock: The FDA News That Has Penny Stock Adamis Pharmaceuticals Rocketing Today
Adamis Pharmaceuticals (ADMP) stock is getting a major boost on Monday thanks to a response from the U.S. Food and Drug Administration. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion.... 
Via Benzinga
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has initiated dosing in the Phase 2/3 trial for Tempol, an oral antiviral product candidate, in adult patients... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Immunology Journal Publishes Data For Adamis' COVID-19 Candidate
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has announced Tempol data publication in the peer-reviewed journal Clinical Immunology. Tempol is a novel... 
Via Benzinga
Exposures COVID-19
Mid-Day Market Update: Macy's Jumps After Q2 Results; PharmaCyte Biotech Shares Drop
Midway through trading Thursday, the Dow traded down 0.40% to 34,819.43 while the NASDAQ rose 0.07% to 14,535.52. The S&P also fell, dropping 0.03% to 4,398.74. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Adamis Announces Results of 2021 Annual Meeting of Stockholders
From Adamis Pharmaceuticals Corporation
Via Business Wire
Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th
From Adamis Pharmaceuticals Corporation
Via Business Wire
Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided Campaign
From Adamis Pharmaceuticals Corporation
Via Business Wire
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434... 
Via Benzinga
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19
From Adamis Pharmaceuticals Corporation
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tenax Therapeutics (NASDAQ:TENX) ... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Midatech Pharma (NASDAQ:MTP) share... 
Via Benzinga
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders
From Adamis Pharmaceuticals Corporation
Via Business Wire
Adamis Pharma Stock Jumps After Naloxone Injection Under FDA Review For Opioid Overdose
The FDA has accepted for review Adamis Pharmaceuticals Corporation's (NASDAQ: ADMP) marketing application seeking approval for Zimhi, a naloxone injection for... 
Via Benzinga
Exposures Product Safety
Adamis Pharma Stock Jumps as NIH Sees Promise in Tempol for COVID-19
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has highlighted that the National Institutes of Health (NIH) has identified its experimental drug, Tempol, as a... 
Via Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Evofem Biosciences (NASDAQ:EVFM) shares increased by 15.4% to $1.0 during Monday's pre-market session. The market value of their outstanding shares is at $152.... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Cyclacel Pharmaceuticals (NASDAQ:CYCC... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) shares rose 35.85% to $2.69 during Friday's regular session. Trading volume for this security as of 12:30 EST is 117.5... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock moved upwards by 29.79% to $2.57 during Friday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Adamis Pharmaceuticals (NASDAQ:ADMP 
Via Benzinga
Why Adamis Shares Are Ripping Higher Today
Shares of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) spiked higher in afternoon trading Thursday following some positive tidings on one of its pipeline assets. What... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tilray (NASDAQ:TLRY) shares incre... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Adamis Pharmaceuticals Corporation (ADMP) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Adamis Pharmaceuticals Corporation (ADMP) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.